12:00 AM
 | 
Sep 01, 2016
 |  BC Extra  |  Company News

Amgen licenses Boehringer MM candidate

Boehringer Ingelheim GmbH (Ingelheim, Germany) granted Amgen Inc. (NASDAQ:AMGN) global rights to develop and commercialize multiple...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >